Perfil
Jon Magne Asmyr served as the Chairman of Nordic Nanovector ASA in 2023.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
THOR MEDICAL ASA
1.98% | 31/07/2023 | 4 647 426 ( 1.98% ) | 447 872 $ | 31/05/2024 |
Antiguos cargos conocidos de Jon Asmyr.
| Empresas | Cargo | Fin |
|---|---|---|
| THOR MEDICAL | Presidente | 28/06/2023 |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
- Bolsa de valores
- Insiders
- Jon Asmyr
